NVAX
Novavax
$7.49
+$0.03 (+0.4%)Jul 27, 2026
Key metrics
The numbers that frame NVAX today
- Market cap
- $1.23B
- P/E (TTM)
- -14.0
- EV / FCF
- -13.3
- Gross margin
- 85%
- EV / Sales
- 2.2
- ROIC
- -9.7%
- Div yield
- 0%
- 52wk Low
- $6.20
- 52wk High
- $11.97
Growth
Revenue and earnings trend for NVAX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NVAX
Is Novavax a good buy?
Hold. Novavax has excellent quality and mixed momentum. The setup is mixed. Growth looks poor. That could put pressure on the long-term business case. We think Novavax is selling at a high price.
What is the market capitalization of NVAX?
Novavax's market capitalization is $1.23B.
What is the P/E ratio for NVAX stock?
Novavax's current P/E ratio is -14.
What is the 52-week high for NVAX stock?
The 52-week high for Novavax is $11.97. The current close of $7.49 is 37.4% below that high.
What is the 52-week low for NVAX stock?
The 52-week low for Novavax is $6.20. The current close of $7.49 is 20.8% above that low.
Does NVAX stock pay dividends?
Novavax does not currently show a dividend per share in the company data.